Literature DB >> 11470551

Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.

O Hornykiewicz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11470551     DOI： 10.1016/s0891-0618(01)00100-4

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN： 0891-0618            Impact factor:   3.052


× No keyword cloud information.
  37 in total

Review 1.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

2.  Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Authors:  Yuan-Hao Chen; Tsung-Hsun Hsieh; Tung-Tai Kuo; Jen-Hsin Kao; Kuo-Hsing Ma; Eagle Yi-Kung Huang; Yu-Ching Chou; Lars Olson; Barry J Hoffer
Journal:  J Neurochem       Date:  2019-05-09       Impact factor: 5.372

3.  Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.

Authors:  Xiomara A Perez; Neeraja Parameswaran; Luping Z Huang; Kathryn T O'Leary; Maryka Quik
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

4.  A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease.

Authors:  Jeff A Beeler; Michael J Frank; John McDaid; Erin Alexander; Susie Turkson; Maria Sol Bernardez Sarria; Maria Sol Bernandez; Daniel S McGehee; Xiaoxi Zhuang
Journal:  Cell Rep       Date:  2012-12-13       Impact factor: 9.423

5.  Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

Authors:  Maryka Quik; Li Chen; Neeraja Parameswaran; Xinmin Xie; J William Langston; Sarah E McCallum
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

6.  Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.

Authors:  Willyan Franco Hilario; Alice Laschuk Herlinger; Lorena Bianchine Areal; Lívia Silveira de Moraes; Tamara Andrea Alarcon Ferreira; Tassiane Emanuelle Servane Andrade; Cristina Martins-Silva; Rita Gomes Wanderley Pires
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

7.  Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.

Authors:  Xiomara A Perez; Kathryn T O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2009-01-14       Impact factor: 4.436

8.  Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat.

Authors:  K Slack; R Billing; S Matthews; H N Allbutt; R Einstein; J M Henderson
Journal:  Parkinsons Dis       Date:  2010-03-21

9.  Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.

Authors:  Li Li; Guozhen Qiu; Shengyuan Ding; Fu-Ming Zhou
Journal:  Brain Res       Date:  2012-11-15       Impact factor: 3.252

10.  Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.

Authors:  L Li; F-M Zhou
Journal:  Neuroscience       Date:  2013-01-26       Impact factor: 3.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.